Cochliomycin A
Cochliomycin A ((+)-Cochliomycin A) can be isolated from Gorgonian-Derived Fungus Cochliobolus lunatus. Cochliomycin A has antifouling activity (EC50: 1.2 μg/mL). Cochliomycin A inhibits barnacle larval settlement by stimulating the NO/cGMP pathway. Cochliomycin A also has moderate antibacterial activity against S. aureus.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1278520-07-2
- Formel: C22H28O7
- Molecular Weight:404.45
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Chemical Information
-
CAS. Nr. 1278520-07-2
-
Molecular Weight 404.45
-
Formel C22H28O7
-
SMILES
OC1=C(C(O[C@H](C/C=C/[C@@](O2)([H])[C@@]3([H])OC2(C)C)C)=O)C(/C=C/C[C@@H]3O)=CC(OC)=C1
-
Synonyms
(+)-Cochliomycin A
-
Structure Classification
-
Initial Source
Cochliobolus lunatus
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Shao CL, et al. Potent antifouling resorcylic acid lactones from the gorgonian-derived fungus Cochliobolus lunatus. J Nat Prod. 2011 Apr 25;74(4):629-33. [Content Brief]
[2]. Wang KL, et al. Cochliomycin A inhibits the larval settlement of Amphibalanus amphitrite by activating the NO/cGMP pathway. Biofouling. 2016;32(1):35-44. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)